chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: arm appears a half inch long tiny blood vessel that may be burst; feels hard; above the injection site is red; above the injection site is hot; inch and a half in size; dark discoloration in the center; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (above the injection site is hot), VACCINATION SITE MASS (inch and a half in size), SKIN DISCOLOURATION (dark discoloration in the center), SKIN HAEMORRHAGE (arm appears a half inch long tiny blood vessel that may be burst) and INJECTION SITE INDURATION (feels hard) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B21A and 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Enlargement of lymph nodes (Patient noticed a week before getting Moderna vaccine, the patient is scheduled for a biopsy) and Cataract. Concomitant products included ALPRAZOLAM for Anxiety, SIMVASTATIN for Cholesterol, DULOXETINE HYDROCHLORIDE (CYMBALTA) for Depression, ATENOLOL for Heart disorder, CLONIDINE (CATAPRESS) for Hypertension, GABAPENTIN for Neuropathy, LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder NOS.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced VACCINATION SITE WARMTH (above the injection site is hot), VACCINATION SITE MASS (inch and a half in size), SKIN DISCOLOURATION (dark discoloration in the center) and VACCINATION SITE ERYTHEMA (above the injection site is red). On 11-Apr-2021, the patient experienced SKIN HAEMORRHAGE (arm appears a half inch long tiny blood vessel that may be burst) and INJECTION SITE INDURATION (feels hard). On 11-Apr-2021, VACCINATION SITE WARMTH (above the injection site is hot), VACCINATION SITE MASS (inch and a half in size), SKIN DISCOLOURATION (dark discoloration in the center) and VACCINATION SITE ERYTHEMA (above the injection site is red) had resolved. At the time of the report, SKIN HAEMORRHAGE (arm appears a half inch long tiny blood vessel that may be burst) and INJECTION SITE INDURATION (feels hard) outcome was unknown.            This case was linked to MOD-2021-073063, MOD-2021-073063 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Headache
Clinical narrative: headache; anxiety; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and ANXIETY (anxiety) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache) and ANXIETY (anxiety). At the time of the report, HEADACHE (headache) and ANXIETY (anxiety) outcome was unknown. Not Provided
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Asthenia, Breast pain, Decreased appetite, Erythema
Clinical narrative: Headache; Muscle aches; upset stomach; doesn't have any appetite; feels like sleeping all the time; doesn't feel right; does not have any energy at all; Redness; she felt more achy around left side of her chest under left breast; Rash; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness), RASH (Rash), BREAST PAIN (she felt more achy around left side of her chest under left breast), HEADACHE (Headache) and MYALGIA (Muscle aches) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history is provided and concomitant drugs are provided.     On 03-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced RASH (Rash). On 04-Apr-2021, the patient experienced ERYTHEMA (Redness) and BREAST PAIN (she felt more achy around left side of her chest under left breast). On an unknown date, the patient experienced HEADACHE (Headache), MYALGIA (Muscle aches), ABDOMINAL DISCOMFORT (upset stomach), DECREASED APPETITE (doesn't have any appetite), SOMNOLENCE (feels like sleeping all the time), FEELING ABNORMAL (doesn't feel right) and ASTHENIA (does not have any energy at all). At the time of the report, ERYTHEMA (Redness), RASH (Rash), BREAST PAIN (she felt more achy around left side of her chest under left breast), HEADACHE (Headache), MYALGIA (Muscle aches), ABDOMINAL DISCOMFORT (upset stomach), DECREASED APPETITE (doesn't have any appetite), SOMNOLENCE (feels like sleeping all the time), FEELING ABNORMAL (doesn't feel right) and ASTHENIA (does not have any energy at all) outcome was unknown. Not Provided          Treatment: acetaminophen (Tylenol) and Heat
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Myalgia, Rash, Somnolence
Clinical narrative: Headache; Muscle aches; upset stomach; doesn't have any appetite; feels like sleeping all the time; doesn't feel right; does not have any energy at all; Redness; she felt more achy around left side of her chest under left breast; Rash; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness), RASH (Rash), BREAST PAIN (she felt more achy around left side of her chest under left breast), HEADACHE (Headache) and MYALGIA (Muscle aches) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history is provided and concomitant drugs are provided.     On 03-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced RASH (Rash). On 04-Apr-2021, the patient experienced ERYTHEMA (Redness) and BREAST PAIN (she felt more achy around left side of her chest under left breast). On an unknown date, the patient experienced HEADACHE (Headache), MYALGIA (Muscle aches), ABDOMINAL DISCOMFORT (upset stomach), DECREASED APPETITE (doesn't have any appetite), SOMNOLENCE (feels like sleeping all the time), FEELING ABNORMAL (doesn't feel right) and ASTHENIA (does not have any energy at all). At the time of the report, ERYTHEMA (Redness), RASH (Rash), BREAST PAIN (she felt more achy around left side of her chest under left breast), HEADACHE (Headache), MYALGIA (Muscle aches), ABDOMINAL DISCOMFORT (upset stomach), DECREASED APPETITE (doesn't have any appetite), SOMNOLENCE (feels like sleeping all the time), FEELING ABNORMAL (doesn't feel right) and ASTHENIA (does not have any energy at all) outcome was unknown. Not Provided          Treatment: acetaminophen (Tylenol) and Heat
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth, Malaise
Clinical narrative: arm is warm; arm is swollen; arm is red (red spreads down to her elbows); arm is itchy; fever; uncomfortable feeling within a few hours; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (uncomfortable feeling within a few hours), INJECTION SITE WARMTH (arm is warm), INJECTION SITE SWELLING (arm is swollen), INJECTION SITE ERYTHEMA (arm is red (red spreads down to her elbows)) and INJECTION SITE PRURITUS (arm is itchy) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history reported).   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced MALAISE (uncomfortable feeling within a few hours). On 09-Apr-2021, the patient experienced INJECTION SITE WARMTH (arm is warm), INJECTION SITE SWELLING (arm is swollen), INJECTION SITE ERYTHEMA (arm is red (red spreads down to her elbows)), INJECTION SITE PRURITUS (arm is itchy) and PYREXIA (fever). At the time of the report, MALAISE (uncomfortable feeling within a few hours), INJECTION SITE WARMTH (arm is warm), INJECTION SITE SWELLING (arm is swollen), INJECTION SITE ERYTHEMA (arm is red (red spreads down to her elbows)), INJECTION SITE PRURITUS (arm is itchy) and PYREXIA (fever) outcome was unknown.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: arm is warm; arm is swollen; arm is red (red spreads down to her elbows); arm is itchy; fever; uncomfortable feeling within a few hours; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (uncomfortable feeling within a few hours), INJECTION SITE WARMTH (arm is warm), INJECTION SITE SWELLING (arm is swollen), INJECTION SITE ERYTHEMA (arm is red (red spreads down to her elbows)) and INJECTION SITE PRURITUS (arm is itchy) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history reported).   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced MALAISE (uncomfortable feeling within a few hours). On 09-Apr-2021, the patient experienced INJECTION SITE WARMTH (arm is warm), INJECTION SITE SWELLING (arm is swollen), INJECTION SITE ERYTHEMA (arm is red (red spreads down to her elbows)), INJECTION SITE PRURITUS (arm is itchy) and PYREXIA (fever). At the time of the report, MALAISE (uncomfortable feeling within a few hours), INJECTION SITE WARMTH (arm is warm), INJECTION SITE SWELLING (arm is swollen), INJECTION SITE ERYTHEMA (arm is red (red spreads down to her elbows)), INJECTION SITE PRURITUS (arm is itchy) and PYREXIA (fever) outcome was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Capillary fragility, Knuckle pads, Petechiae, Vasodilatation
Clinical narrative: Top of the left hand shows broken capillaries; Some sport of blood coming out of those broken capillaries; Huge blood veins sticking out of patient's wrist like a snake; Bumps over both the knuckles.; This spontaneous case was reported by a consumer and describes the occurrence of PETECHIAE (Top of the left hand shows broken capillaries), CAPILLARY FRAGILITY (Some sport of blood coming out of those broken capillaries), VASODILATATION (Huge blood veins sticking out of patient's wrist like a snake) and KNUCKLE PADS (Bumps over both the knuckles.) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     Concurrent medical conditions included Back pain. Concomitant products included DICLOFENAC SODIUM (PROFENAC) for Back pain, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (SINUS MEDICATION) for an unknown indication.   On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Mar-2021, the patient experienced PETECHIAE (Top of the left hand shows broken capillaries), CAPILLARY FRAGILITY (Some sport of blood coming out of those broken capillaries), VASODILATATION (Huge blood veins sticking out of patient's wrist like a snake) and KNUCKLE PADS (Bumps over both the knuckles.). At the time of the report, PETECHIAE (Top of the left hand shows broken capillaries), CAPILLARY FRAGILITY (Some sport of blood coming out of those broken capillaries), VASODILATATION (Huge blood veins sticking out of patient's wrist like a snake) and KNUCKLE PADS (Bumps over both the knuckles.) had not resolved.            Other Concomitant product information includes Supplements. Treatment information was not provided.   This case was linked to MOD-2021-073125 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Outcome of the events were changed from unknown to not recovered.Symptoms are still ongoing.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Influenza like illness, Myalgia, Pyrexia
Clinical narrative: Flu like symptoms; Generalized aching; Chills; Fever; This spontaneous case was reported by a physician and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), MYALGIA (Generalized aching), CHILLS (Chills) and PYREXIA (Fever) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB for Plaque psoriasis.    No Medical History information was reported.   On 18-Nov-2020, the patient started RISANKIZUMAB (Subcutaneous) at an unspecified dose. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), MYALGIA (Generalized aching), CHILLS (Chills) and PYREXIA (Fever). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), MYALGIA (Generalized aching), CHILLS (Chills) and PYREXIA (Fever) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.  Concomitant medication not provided.  Treatment information not provided.   This case was linked to MOD-2021-033451 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Loss of personal independence in daily activities, Musculoskeletal stiffness, Pain, Pain in extremity
Clinical narrative: sore arm; lower back pain; stiff lower back; pain that interferes with her daily activities; pain that interferes with her daily activities; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), BACK PAIN (lower back pain), MUSCULOSKELETAL STIFFNESS (stiff lower back), PAIN (pain that interferes with her daily activities) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (pain that interferes with her daily activities) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     The patient's past medical history included Viral meningitis. Concurrent medical conditions included Penicillin allergy and Thyroid disorder NOS. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder NOS, MAGNESIUM and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm), BACK PAIN (lower back pain), MUSCULOSKELETAL STIFFNESS (stiff lower back), PAIN (pain that interferes with her daily activities) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (pain that interferes with her daily activities). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm), BACK PAIN (lower back pain), MUSCULOSKELETAL STIFFNESS (stiff lower back), PAIN (pain that interferes with her daily activities) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (pain that interferes with her daily activities) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient took 2 doses of Tylenol extra strength (2 tabs per administration - a total of 4 tabs) a a corrective treatment. She thought she might be taking naproxen later. The patient stated she is sure that what she is feeling right now is viral.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Ear haemorrhage
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of EAR HAEMORRHAGE (bleeding from her right ear) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 19-MAR-2021 00:00) for an unknown indication.     The patient's past medical history included No adverse event. Concomitant products included WARFARIN SODIUM (COUMADIN).    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced EAR HAEMORRHAGE (bleeding from her right ear). On 20-Mar-2021, EAR HAEMORRHAGE (bleeding from her right ear) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Device connection issue, Underdose, Vaccination site pain
Clinical narrative: When getting the shot, the vaccine or fluid in the syringe was dripping on the arm; When getting the shot, the vaccine or fluid in the syringe was dripping on the arm; Tiny bity pain tenderness and soreness on the injection site at her left arm; This spontaneous case was reported by a physician and describes the occurrence of DEVICE CONNECTION ISSUE (When getting the shot, the vaccine or fluid in the syringe was dripping on the arm), UNDERDOSE (When getting the shot, the vaccine or fluid in the syringe was dripping on the arm) and VACCINATION SITE PAIN (Tiny bity pain tenderness and soreness on the injection site at her left arm) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy and Allergy to antibiotic.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced DEVICE CONNECTION ISSUE (When getting the shot, the vaccine or fluid in the syringe was dripping on the arm), UNDERDOSE (When getting the shot, the vaccine or fluid in the syringe was dripping on the arm) and VACCINATION SITE PAIN (Tiny bity pain tenderness and soreness on the injection site at her left arm). On 05-Apr-2021, DEVICE CONNECTION ISSUE (When getting the shot, the vaccine or fluid in the syringe was dripping on the arm) and UNDERDOSE (When getting the shot, the vaccine or fluid in the syringe was dripping on the arm) had resolved. At the time of the report, VACCINATION SITE PAIN (Tiny bity pain tenderness and soreness on the injection site at her left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was not Applicable.   This case was linked to MOD-2021-178629 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow up received on 26 May 2021 had new information regarding reporter, patient, allergies and information regarding second dose.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Body temperature, Chills, Diarrhoea, Movement disorder
Clinical narrative: 104F temperature; shaking; chills; couldn't move her arms; vomiting; diarrhea; losing her taste; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (104F temperature), TREMOR (shaking), CHILLS (chills), MOVEMENT DISORDER (couldn't move her arms) and VOMITING (vomiting) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. A16B214 and 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced PYREXIA (104F temperature), TREMOR (shaking), CHILLS (chills), MOVEMENT DISORDER (couldn't move her arms), VOMITING (vomiting), DIARRHOEA (diarrhea) and AGEUSIA (losing her taste). At the time of the report, PYREXIA (104F temperature), TREMOR (shaking), CHILLS (chills), MOVEMENT DISORDER (couldn't move her arms), VOMITING (vomiting), DIARRHOEA (diarrhea) and AGEUSIA (losing her taste) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Apr-2021, Body temperature: 104 104F.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Tremor, Vomiting
Clinical narrative: 104F temperature; shaking; chills; couldn't move her arms; vomiting; diarrhea; losing her taste; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (104F temperature), TREMOR (shaking), CHILLS (chills), MOVEMENT DISORDER (couldn't move her arms) and VOMITING (vomiting) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. A16B214 and 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced PYREXIA (104F temperature), TREMOR (shaking), CHILLS (chills), MOVEMENT DISORDER (couldn't move her arms), VOMITING (vomiting), DIARRHOEA (diarrhea) and AGEUSIA (losing her taste). At the time of the report, PYREXIA (104F temperature), TREMOR (shaking), CHILLS (chills), MOVEMENT DISORDER (couldn't move her arms), VOMITING (vomiting), DIARRHOEA (diarrhea) and AGEUSIA (losing her taste) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Apr-2021, Body temperature: 104 104F.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, Rash
Clinical narrative: Rash; Body pains; Muscle pains; Fever; This spontaneous case was reported by a non-health professional and describes the occurrence of RASH (Rash), MYALGIA (Body pains), MYALGIA (Muscle pains) and PYREXIA (Fever) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced RASH (Rash), MYALGIA (Body pains), MYALGIA (Muscle pains) and PYREXIA (Fever). At the time of the report, RASH (Rash) and PYREXIA (Fever) had resolved and MYALGIA (Body pains) and MYALGIA (Muscle pains) outcome was unknown.        Treatment information was not provided.  The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event is not applicable.  On the night of the second dose (12Feb2021) patient started with fever, a rash, muscle and body pains.Sometimes, patient can't sleep because of the pains. Patient didn't contact with doctor to discuss the symptoms. Patient didn't take any medication to treat symptoms. Patient asks if it is normal for the side effects to last this long.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: local pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (local pain at the injection site) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     Concurrent medical conditions included Latex allergy.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE PAIN (local pain at the injection site). On 08-Mar-2021, VACCINATION SITE PAIN (local pain at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided   This case was linked to MOD-2021-073118 (Patient Link).
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Bursitis, Chest discomfort, Dysstasia, Osteoarthritis
Clinical narrative: Tendonitis; Bursitis; Severe R hip pain; Unable to stand upright; Borederline Acetabular Osteoarthritis; ACHES INTENSIFIED; INTOLERABLE BREATH TAKING PAIN; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (ACHES INTENSIFIED), CHEST DISCOMFORT (INTOLERABLE BREATH TAKING PAIN), DYSSTASIA (Unable to stand upright), ARTHRALGIA (Severe R hip pain) and OSTEOARTHRITIS (Borederline Acetabular Osteoarthritis) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Tendonitis on 12-Mar-2021 and Bursitis on 12-Mar-2021. Concomitant products included RALOXIFENE HYDROCHLORIDE (EVISTA) for Bone density abnormal, PITAVASTATIN CALCIUM (LIVALO) for Cholesterol, CURCUMA LONGA, LEVOMEFOLIC ACID, MECOBALAMIN (RHEUMATE) for Dietary control, IBUPROFEN (MOTRIN [IBUPROFEN]) from 17-Feb-2021 to an unknown date and METHYLPREDNISOLONE ACETATE (DEPO MEDROL) from 05-Mar-2021 to 07-Mar-2021 for Pain, KETOROLAC TROMETHAMINE (TORADOL) from 05-Mar-2021 to 07-Mar-2021 for Pain NOS.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced PAIN (ACHES INTENSIFIED) and CHEST DISCOMFORT (INTOLERABLE BREATH TAKING PAIN). On 05-Mar-2021, the patient experienced DYSSTASIA (Unable to stand upright), ARTHRALGIA (Severe R hip pain) and OSTEOARTHRITIS (Borederline Acetabular Osteoarthritis). On 12-Mar-2021, the patient experienced TENDONITIS (Tendonitis) and BURSITIS (Bursitis). On 25-Feb-2021, PAIN (ACHES INTENSIFIED) and CHEST DISCOMFORT (INTOLERABLE BREATH TAKING PAIN) had not resolved. At the time of the report, DYSSTASIA (Unable to stand upright), ARTHRALGIA (Severe R hip pain), OSTEOARTHRITIS (Borederline Acetabular Osteoarthritis), TENDONITIS (Tendonitis) and BURSITIS (Bursitis) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, X-ray: (abnormal) Borderline acetabular osteoarthritis..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    April 7th 2021, Patient  pain is easing, able to walk upright and is decreasing the treatment of Motrin.       Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: Non-significant follow-up
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Tendonitis, X-ray
Clinical narrative: Tendonitis; Bursitis; Severe R hip pain; Unable to stand upright; Borederline Acetabular Osteoarthritis; ACHES INTENSIFIED; INTOLERABLE BREATH TAKING PAIN; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (ACHES INTENSIFIED), CHEST DISCOMFORT (INTOLERABLE BREATH TAKING PAIN), DYSSTASIA (Unable to stand upright), ARTHRALGIA (Severe R hip pain) and OSTEOARTHRITIS (Borederline Acetabular Osteoarthritis) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Tendonitis on 12-Mar-2021 and Bursitis on 12-Mar-2021. Concomitant products included RALOXIFENE HYDROCHLORIDE (EVISTA) for Bone density abnormal, PITAVASTATIN CALCIUM (LIVALO) for Cholesterol, CURCUMA LONGA, LEVOMEFOLIC ACID, MECOBALAMIN (RHEUMATE) for Dietary control, IBUPROFEN (MOTRIN [IBUPROFEN]) from 17-Feb-2021 to an unknown date and METHYLPREDNISOLONE ACETATE (DEPO MEDROL) from 05-Mar-2021 to 07-Mar-2021 for Pain, KETOROLAC TROMETHAMINE (TORADOL) from 05-Mar-2021 to 07-Mar-2021 for Pain NOS.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced PAIN (ACHES INTENSIFIED) and CHEST DISCOMFORT (INTOLERABLE BREATH TAKING PAIN). On 05-Mar-2021, the patient experienced DYSSTASIA (Unable to stand upright), ARTHRALGIA (Severe R hip pain) and OSTEOARTHRITIS (Borederline Acetabular Osteoarthritis). On 12-Mar-2021, the patient experienced TENDONITIS (Tendonitis) and BURSITIS (Bursitis). On 25-Feb-2021, PAIN (ACHES INTENSIFIED) and CHEST DISCOMFORT (INTOLERABLE BREATH TAKING PAIN) had not resolved. At the time of the report, DYSSTASIA (Unable to stand upright), ARTHRALGIA (Severe R hip pain), OSTEOARTHRITIS (Borederline Acetabular Osteoarthritis), TENDONITIS (Tendonitis) and BURSITIS (Bursitis) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, X-ray: (abnormal) Borderline acetabular osteoarthritis..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    April 7th 2021, Patient  pain is easing, able to walk upright and is decreasing the treatment of Motrin.       Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: Non-significant follow-up
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: full body rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (full body rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (full body rash). At the time of the report, RASH (full body rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment medication includes: Steroids
Sex: F
Vaccine: COVID19
Symptoms: Eye pruritus, Eye swelling, Pain, Pain in extremity, Product dose omission issue
Clinical narrative: eyelids still swollen; eyes are itchy and red; cancelled second dose; a lot of pain in her left arm; intense pain down to tip of her fingers; eyes swollen shut; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Apr-2021 and was forwarded to Moderna on 09-Apr-2021.    This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Apr-2021 and was forwarded to Moderna on 09-Apr-2021.    This spontaneous case was reported by a  and describes the occurrence of EYE SWELLING (eyes swollen shut), PAIN IN EXTREMITY (a lot of pain in her left arm), PAIN (intense pain down to tip of her fingers), SWELLING OF EYELID (eyelids still swollen) and EYE PRURITUS (eyes are itchy and red) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A27A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced EYE SWELLING (eyes swollen shut). On an unknown date, the patient experienced PAIN IN EXTREMITY (a lot of pain in her left arm), PAIN (intense pain down to tip of her fingers), SWELLING OF EYELID (eyelids still swollen), EYE PRURITUS (eyes are itchy and red) and PRODUCT DOSE OMISSION ISSUE (cancelled second dose). At the time of the report, EYE SWELLING (eyes swollen shut), PAIN IN EXTREMITY (a lot of pain in her left arm), PAIN (intense pain down to tip of her fingers), SWELLING OF EYELID (eyelids still swollen), EYE PRURITUS (eyes are itchy and red) and PRODUCT DOSE OMISSION ISSUE (cancelled second dose) had not resolved. Not applicable      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Swelling of eyelid
Clinical narrative: eyelids still swollen; eyes are itchy and red; cancelled second dose; a lot of pain in her left arm; intense pain down to tip of her fingers; eyes swollen shut; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Apr-2021 and was forwarded to Moderna on 09-Apr-2021.    This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Apr-2021 and was forwarded to Moderna on 09-Apr-2021.    This spontaneous case was reported by a  and describes the occurrence of EYE SWELLING (eyes swollen shut), PAIN IN EXTREMITY (a lot of pain in her left arm), PAIN (intense pain down to tip of her fingers), SWELLING OF EYELID (eyelids still swollen) and EYE PRURITUS (eyes are itchy and red) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A27A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced EYE SWELLING (eyes swollen shut). On an unknown date, the patient experienced PAIN IN EXTREMITY (a lot of pain in her left arm), PAIN (intense pain down to tip of her fingers), SWELLING OF EYELID (eyelids still swollen), EYE PRURITUS (eyes are itchy and red) and PRODUCT DOSE OMISSION ISSUE (cancelled second dose). At the time of the report, EYE SWELLING (eyes swollen shut), PAIN IN EXTREMITY (a lot of pain in her left arm), PAIN (intense pain down to tip of her fingers), SWELLING OF EYELID (eyelids still swollen), EYE PRURITUS (eyes are itchy and red) and PRODUCT DOSE OMISSION ISSUE (cancelled second dose) had not resolved. Not applicable      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Mastication disorder, Mumps, Swelling face
Clinical narrative: Mumps like symptoms on left side of face; Chewing is painful/ Difficulty in chewing on left side; Swelling of face left side; This spontaneous case was reported by a consumer and describes the occurrence of MUMPS (Mumps like symptoms on left side of face), MASTICATION DISORDER (Chewing is painful/ Difficulty in chewing on left side) and SWELLING FACE (Swelling of face left side) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Mumps.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced MUMPS (Mumps like symptoms on left side of face), MASTICATION DISORDER (Chewing is painful/ Difficulty in chewing on left side) and SWELLING FACE (Swelling of face left side). At the time of the report, MUMPS (Mumps like symptoms on left side of face), MASTICATION DISORDER (Chewing is painful/ Difficulty in chewing on left side) and SWELLING FACE (Swelling of face left side) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included unspecified blood pressure and  cholesterol medications.No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Follow-up information received on 16 Jun 2021 contains non-significant information.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement
Clinical narrative: Blood pressure Spike after second dose; This spontaneous case was reported by an other caregiver and describes the occurrence of BLOOD PRESSURE INCREASED (Blood pressure Spike after second dose) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history is provided and concomitant drugs are provided.     On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced BLOOD PRESSURE INCREASED (Blood pressure Spike after second dose). At the time of the report, BLOOD PRESSURE INCREASED (Blood pressure Spike after second dose) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Apr-2021, Blood pressure measurement: spike spike in blood pressure.         other concomitant medication include single blood pressure medication taken twice daily.  No treatment reported.   patient wants to know if she should continue taking her blood pressure medication given the reaction that she had after her second dose.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: rashes inside of arm, rashes outside of breast and down a little bit/rashes flare ups; Itchy; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rashes inside of arm, rashes outside of breast and down a little bit/rashes flare ups) and PRURITUS (Itchy) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (rashes inside of arm, rashes outside of breast and down a little bit/rashes flare ups) and PRURITUS (Itchy). At the time of the report, RASH (rashes inside of arm, rashes outside of breast and down a little bit/rashes flare ups) had not resolved and PRURITUS (Itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were provided. No treatment details were provided. Crosslinked to original case. MOD21-073281   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Fallow up received and contains no new information.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling cold, Freezing phenomenon, Gait disturbance
Clinical narrative: totally stiff and totally sore; terrible body ache; hardly walk; freezing to the bones; chills; feeling exhausted; pain at right arm; with nightmares; flu like symptoms; sweats; shaking; coldness; This spontaneous case was reported by a health care professional and describes the occurrence of MUSCULOSKELETAL STIFFNESS (totally stiff and totally sore), PAIN (terrible body ache), GAIT DISTURBANCE (hardly walk), FREEZING PHENOMENON (freezing to the bones) and NIGHTMARE (with nightmares) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: FLU VACCINE VII (similar symptoms.). Concurrent medical conditions included Spinal stenosis (undergone operation.), Arthritis, Blood pressure management and Cholesterol. Concomitant products included PARACETAMOL (TYLENOL) for Arthritis, AMLODIPINE BESILATE (NORVASC) and IRBESARTAN (AVAPRO) for Blood pressure management, PRAVASTATIN for Cholesterol, METAXALONE for Muscle relaxant, DIAZEPAM (VALIUM) for an unknown indication.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced NIGHTMARE (with nightmares) and VACCINATION SITE PAIN (pain at right arm). On 10-Apr-2021, the patient experienced FATIGUE (feeling exhausted). On 11-Apr-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (totally stiff and totally sore), PAIN (terrible body ache), GAIT DISTURBANCE (hardly walk), FREEZING PHENOMENON (freezing to the bones) and CHILLS (chills). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), HYPERHIDROSIS (sweats), TREMOR (shaking) and FEELING COLD (coldness). On 09-Apr-2021, VACCINATION SITE PAIN (pain at right arm) had resolved. At the time of the report, MUSCULOSKELETAL STIFFNESS (totally stiff and totally sore), PAIN (terrible body ache), GAIT DISTURBANCE (hardly walk), FREEZING PHENOMENON (freezing to the bones), NIGHTMARE (with nightmares), INFLUENZA LIKE ILLNESS (flu like symptoms), HYPERHIDROSIS (sweats), TREMOR (shaking), FEELING COLD (coldness), CHILLS (chills) and FATIGUE (feeling exhausted) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment includedm1 Skalexin, tylenol and Vallium before bed and one Tylenol in morning.   This case was linked to MOD21-073300 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Events (Hyperhidrosis, tremor, feeling cold) were added and event pain in extremity updated to vaccination site pain. Patient received second dose on 07 May 2021.; Sender's Comments:  MOD21-073300:Link to Dose 2 MOD-2021-123837
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Influenza like illness, Musculoskeletal stiffness, Nightmare, Pain
Clinical narrative: totally stiff and totally sore; terrible body ache; hardly walk; freezing to the bones; chills; feeling exhausted; pain at right arm; with nightmares; flu like symptoms; sweats; shaking; coldness; This spontaneous case was reported by a health care professional and describes the occurrence of MUSCULOSKELETAL STIFFNESS (totally stiff and totally sore), PAIN (terrible body ache), GAIT DISTURBANCE (hardly walk), FREEZING PHENOMENON (freezing to the bones) and NIGHTMARE (with nightmares) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: FLU VACCINE VII (similar symptoms.). Concurrent medical conditions included Spinal stenosis (undergone operation.), Arthritis, Blood pressure management and Cholesterol. Concomitant products included PARACETAMOL (TYLENOL) for Arthritis, AMLODIPINE BESILATE (NORVASC) and IRBESARTAN (AVAPRO) for Blood pressure management, PRAVASTATIN for Cholesterol, METAXALONE for Muscle relaxant, DIAZEPAM (VALIUM) for an unknown indication.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced NIGHTMARE (with nightmares) and VACCINATION SITE PAIN (pain at right arm). On 10-Apr-2021, the patient experienced FATIGUE (feeling exhausted). On 11-Apr-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (totally stiff and totally sore), PAIN (terrible body ache), GAIT DISTURBANCE (hardly walk), FREEZING PHENOMENON (freezing to the bones) and CHILLS (chills). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), HYPERHIDROSIS (sweats), TREMOR (shaking) and FEELING COLD (coldness). On 09-Apr-2021, VACCINATION SITE PAIN (pain at right arm) had resolved. At the time of the report, MUSCULOSKELETAL STIFFNESS (totally stiff and totally sore), PAIN (terrible body ache), GAIT DISTURBANCE (hardly walk), FREEZING PHENOMENON (freezing to the bones), NIGHTMARE (with nightmares), INFLUENZA LIKE ILLNESS (flu like symptoms), HYPERHIDROSIS (sweats), TREMOR (shaking), FEELING COLD (coldness), CHILLS (chills) and FATIGUE (feeling exhausted) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment includedm1 Skalexin, tylenol and Vallium before bed and one Tylenol in morning.   This case was linked to MOD21-073300 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Events (Hyperhidrosis, tremor, feeling cold) were added and event pain in extremity updated to vaccination site pain. Patient received second dose on 07 May 2021.; Sender's Comments:  MOD21-073300:Link to Dose 2 MOD-2021-123837